Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand
摘要:
Cyclic tetrapeptide retrohydroxamic acids were prepared as historic deacetylase (HDAC) inhibitors and evaluated the inhibitory activity and found that they have potential as anticancer drugs. (C) 2004 Elsevier Ltd. All rights reserved.
Comparative α-Helicity of Cyclic Pentapeptides in Water
作者:Aline D. de Araujo、Huy N. Hoang、W. Mei Kok、Frederik Diness、Praveer Gupta、Timothy A. Hill、Russell W. Driver、David A. Price、Spiros Liras、David P. Fairlie
DOI:10.1002/anie.201310245
日期:2014.7.1
α‐helix induction in simple model pentapeptides, Ac‐cyclo(1,5)‐[X1‐Ala‐Ala‐Ala‐X5]‐NH2, in water. In this very stringent test of helix induction, a Lys1→Asp5 lactam linker conferred greatest α‐helicity, hydrocarbon and triazole linkers induced a mix of α‐ and 310‐helicity, while thio‐ and dithioether linkers produced less helicity. The lactam‐linked cyclicpentapeptide was also the most effective α‐helix
An efficient access to both enantiomers of pipecolic acid
作者:Louis A. Watanabe、Saori Haranaka、Binoy Jose、Minoru Yoshida、Tamaki Kato、Mitsuaki Moriguchi、Kenji Soda、Norikazu Nishino
DOI:10.1016/j.tetasy.2005.01.017
日期:2005.2
An efficient and convenient synthesis of bothenantiomers of pipecolicacid has been developed using the intramolecular cyclization of 2-amino-6-bromohexanoic acid under mild conditions.
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand
作者:Norikazu Nishino、Daisuke Yoshikawa、Louis A. Watanabe、Tamaki Kato、Binoy Jose、Yasuhiko Komatsu、Yuko Sumida、Minoru Yoshida
DOI:10.1016/j.bmcl.2004.03.018
日期:2004.5
Cyclic tetrapeptide retrohydroxamic acids were prepared as historic deacetylase (HDAC) inhibitors and evaluated the inhibitory activity and found that they have potential as anticancer drugs. (C) 2004 Elsevier Ltd. All rights reserved.
Inhibitors selective for HDAC6 in enzymes and cells
作者:Praveer K. Gupta、Robert C. Reid、Ligong Liu、Andrew J. Lucke、Steve A. Broomfield、Melanie R. Andrews、Matthew J. Sweet、David P. Fairlie
DOI:10.1016/j.bmcl.2010.09.100
日期:2010.12
Histone deacetylase inhibitors with anticancer or anti-inflammatory activity bind to Class I or Class I and II HDAC enzymes. Here we compare selectivity of inhibitors of a Class II HDAC enzyme (HDAC6) and find one that retains high selectivity in macrophages. (C) 2010 Elsevier Ltd. All rights reserved.